Intron a and Acyclovir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Intron a (interferon alfa-2b) and Acyclovir (acyclovir). Common drug interactions include respiratory tract infection viral among females and pulmonary hypertension among males.

The phase IV clinical study analyzes what interactions people have when they take Intron a and Acyclovir. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Intron a?

Intron a has active ingredients of interferon alfa-2b. eHealthMe is studying from 9,320 Intron a users. Check the latest studies of Intron a.

What is Acyclovir?

Acyclovir has active ingredients of acyclovir. It is often used in herpes simplex. eHealthMe is studying from 54,961 Acyclovir users. Check the latest studies of Acyclovir.



On Jul, 16, 2026

12 people who take Intron a and Acyclovir together, and have interactions are studied.

Intron a and Acyclovir drug interactions.

What are the common drug interactions of Intron A and Acyclovir, by gender? *:

female:

  1. Respiratory tract infection viral
  2. Scoliosis (a medical condition in which a person's spine is curved from side to side)
  3. Sjogren's syndrome (a disease that causes dryness in the mouth and eyes)
  4. Spinal fusion surgery
  5. Syncope (loss of consciousness with an inability to maintain postural tone)
  6. Thyroid disorder (thyroid diseases)
  7. Tobacco abuse
  8. Upper respiratory tract infection
  9. Vitamin b12 deficiency
  10. Vitamin d deficiency

male:

  1. Pulmonary hypertension (increase in blood pressure in the lung artery)
  2. Heart transplant
  3. Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function)
  4. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  5. Diplopia (double vision)
  6. Drug maladministration
  7. Dyspnoea (difficult or laboured respiration)
  8. Encephalitis (inflammation of the brain)
  9. Enterobacter bacteraemia (enterobacter cloacae are nosocomial pathogens that can cause a range of infections such as bacteraemia, lower respiratory tract infection, skin)
  10. Fatigue (feeling of tiredness)

What are the common drug interactions of Intron A and Acyclovir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Heart transplant
  2. Pulmonary hypertension (increase in blood pressure in the lung artery)
  3. Restrictive cardiomyopathy (a condition in which the walls of the lower chambers of the heart (the ventricles) are abnormally rigid and lack the flexibility)

10-19:

  1. Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function)
  2. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  3. Diplopia (double vision)
  4. Encephalitis (inflammation of the brain)
  5. Fatigue (feeling of tiredness)
  6. Headache (pain in head)
  7. Infection
  8. Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  9. Pyrexia (fever)
  10. Upper respiratory tract infection

20-29:

  1. Cardiac failure
  2. Cardiomegaly (increased size of heart than normal)
  3. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  4. Drug maladministration
  5. Dyspnoea (difficult or laboured respiration)
  6. Hoarseness (changing voice)
  7. Hypoxia (low oxygen in tissues)
  8. Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
  9. Pulmonary function test nos decreased
  10. Pulmonary hypertension (increase in blood pressure in the lung artery)

30-39:

  1. Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)

40-49:

  1. Anaphylactic reaction (serious allergic reaction)
  2. Asthma
  3. Blood carbon dioxide decreased
  4. Bronchiolitis (inflammation of the membranes lining the bronchioles in lungs)
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
  7. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  8. Chronic obstructive airways disease
  9. Cough
  10. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)

50-59:

  1. Hepatitis c
  2. Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)
  3. Infection in an immunocompromised host
  4. Leukocytosis (increased white blood cells)
  5. Leukopenia (less number of white blood cells in blood)
  6. Peritonitis bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial)
  7. Pulmonary granuloma (tiny lump of inflamed tissue in the lungs)
  8. Renal failure acute (rapid kidney dysfunction)
  9. Respiratory failure (inadequate gas exchange by the respiratory system)
  10. Staphylococcal bacteraemia (a bacterial infection of blood)

60+:

  1. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Infection
  4. Retinopathy (acute damage to the retina of the eye)

What are the existing conditions these people have? *

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 25.00%
  2. Viral Infection: 2 people, 16.67%
  3. Hepatitis C: 2 people, 16.67%
  4. Multiple Myeloma (cancer of the plasma cells): 1 person, 8.33%
  5. Malignant Melanoma (skin cancer rises from melancytes): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Intron a and Acyclovir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Intron a and Acyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Intron a:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Acyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Intron a and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acyclovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on interferon alfa-2b and acyclovir (the active ingredients of Intron a and Acyclovir, respectively), and Intron a and Acyclovir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: